MedPath

Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry

Active, not recruiting
Conditions
Obstructive Sleep Apnea
Interventions
Device: Inspire therapy
Other: No intervention
Registration Number
NCT02907398
Lead Sponsor
Inspire Medical Systems, Inc.
Brief Summary

Inspire intends to conduct this registry to: 1) collect Inspire therapy clinical evidence in the clinical practice setting; 2) collect additional information on the effectiveness, use and safety in the commercial setting; and 3) engage physician customers to report the collective outcome within a group of properly trained programs that utilize Inspire therapy on a regular basis.

In addition, a sub-study will be conducted under this Registry at a limited number of Registry centers and will include a cohort of Registry patients and a cohort of patients who have not received the Inspire therapy device due to denial of insurance coverage. The two sub-study cohorts' quality of life and AHI data will be compared.

Detailed Description

This registry is a multi-center, prospective, observational registry, conducted in the United States and Europe. Some data may be collected retrospectively in patients currently implanted (implanted prior to enrollment) through the 12-month follow-up time frame. The CE-marked and FDA-approved Inspire system will be used within its intended use, allowing for of use of any future approved system component models. This protocol does not include any additional stressful or invasive tests, which are not a part of standard of care.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria

Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry:

  1. Capable of giving informed consent, as required per institution
  2. Willing to return for routine clinic visits as required for Inspire therapy management
Exclusion Criteria

Any patient who meets any of the following criteria will not be eligible to participate in the registry

  1. Has a life expectancy of less than 1 year
  2. Any reason the clinician deems patient is unfit for participation in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ADHEREInspire therapyThis group will include 250 patients who have been implanted with the Inspire therapy system, enrolled in the ADHERE Registry, and are willing to complete a follow-up home sleep apnea test (HSAT).
CONTROLNo interventionThis group will include 100 patients who have been denied insurance coverage of the Inspire therapy system implant by their provider, have had no intervention (Inspire), and are willing to complete a HSAT and provide information about their OSA treatment after denial.
Primary Outcome Measures
NameTimeMethod
Change in Apnea Hypopnea (AHI) from Baseline to 12-MonthsBaseline through 12 months

Apnea Hypopnea Index (AHI) is a measure of OSA severity. The AHI will be determined by the AHI score at the post-titration visit compared with the pre-implant baseline score.

Change in Epworth Sleepiness Scale (ESS) from Baseline to 12 MonthsBaseline through 12 months

The Epworth Sleepiness Scale (ESS) is a validated instruction that rates a subject's daytime sleepiness. ESS scores range from 0 to 24, with a lower score indicating less daytime sleepiness. An ESS score of 10 or less is equivalent to the normalized population. The ESS efficacy endpoint will be determined by the ESS score at the 12-month follow-up as compared to baseline.

Secondary Outcome Measures
NameTimeMethod
Therapy AdherenceThrough 12 months

Therapy use, reported as hours of use per week, is record by Inspire device and can be collected upon interrogation of the device in the clinic. This value can be used to quantify device use and adherence over time.

Advance or Additional TitrationsThrough 12 months

The patient will report the number of in-office or sleep lab device titrations completed.

Patient Experience with Therapy (PET)Through 12 months

The PET is a survey deigned to collect information about patients' experience with the Inspire therapy. Information will be collected once the therapy is activated about relative satisfaction with the therapy over time.

Insomnia Severity Index (ISI)Baseline through 12 months

The Insomnia Severity Index (ISI) is a 7 item self-report instrument that measures patient perception of both nocturnal and diurnal symptoms of insomnia. Scores range from 0 to 28, with a lower score indicating less severe insomnia.

Physical AssessmentBaseline through 12 months

Blood pressure, and height (in either cm or in) \& weight (in either kg or lbs) will be used to calculate Body Mass Index at baseline and through study completion.

Clinical Global Impression (CGI-I)Baseline through 12 months

The Clinical Global Impression (CGI-I) is a clinician assessment of how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention. During the assessment the physician rates the patient's obstructive sleep apnea by selecting 1 of 7 categories that range from very much worse to very much improved (in comparison to baseline).

Device Data CollectionThrough 12 months

Device programming and adjustment data recorded during follow-up visits will be collected from physician and patient programmers.

Trial Locations

Locations (62)

Central Florida Pulmonary

🇺🇸

Orlando, Florida, United States

Valley Sleep Center

🇺🇸

Mesa, Arizona, United States

The University of Alabama for the University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Valley ENT

🇺🇸

Scottsdale, Arizona, United States

The Neurology Center of Southern California

🇺🇸

Carlsbad, California, United States

University of Southern California

🇺🇸

Los Angeles, California, United States

Stanford University Medical Center

🇺🇸

Redwood City, California, United States

University of Colorado Denver

🇺🇸

Aurora, Colorado, United States

Middlesex Hospital

🇺🇸

New Haven, Connecticut, United States

MedStar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

University of Florida Health

🇺🇸

Gainesville, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

Augusta University

🇺🇸

Augusta, Georgia, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Northshore University Hospital

🇺🇸

Glenview, Illinois, United States

Indiana University School of Medicine

🇺🇸

Indianapolis, Indiana, United States

Richard L Roudebush VA Medical Center

🇺🇸

Indianapolis, Indiana, United States

University of Iowa

🇺🇸

Iowa City, Iowa, United States

The University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

Advanced ENT and Allergy

🇺🇸

Louisville, Kentucky, United States

Wayne State University

🇺🇸

Dearborn, Michigan, United States

Michigan Heart - St Joseph Mercy Health System

🇺🇸

Ypsilanti, Michigan, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

St. Cloud Ear, Nose and Throat Clinic

🇺🇸

St. Cloud, Minnesota, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

St. Luke's Hospital

🇺🇸

Chesterfield, Missouri, United States

Hackensack Meridian Health

🇺🇸

Hackensack, New Jersey, United States

Long Island Jewish/Northwell Health

🇺🇸

New Hyde Park, New York, United States

Weill Cornell Medicine

🇺🇸

New York, New York, United States

Cincinnati VA Medical Center

🇺🇸

Cincinnati, Ohio, United States

Sleep Management Institute

🇺🇸

Cincinnati, Ohio, United States

University Hospitals Case Western

🇺🇸

Cleveland, Ohio, United States

MetroHealth Systems

🇺🇸

Cleveland, Ohio, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Ohio State University

🇺🇸

Columbus, Ohio, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Pennsylvania Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Thomas Jefferson University and Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Reading Hospital

🇺🇸

Reading, Pennsylvania, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

University of Tennessee Health Science Center/ Baptist Hospital

🇺🇸

Memphis, Tennessee, United States

Universitatsklinikum Hamburg Eppendorf

🇩🇪

Hamburge, Germany

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

University of Texas Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

Ogden Clinic

🇺🇸

Ogden, Utah, United States

Virginia Heart Center for Sleep and Wellness

🇺🇸

Fairfax, Virginia, United States

Virginia Commonwealth University

🇺🇸

Richmond, Virginia, United States

Puget Sound ENT

🇺🇸

Edmonds, Washington, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

Universitair Ziekenhuis Antwerpen

🇧🇪

Edegem, Belgium

Technische Universitat Dresden

🇩🇪

Dresden, Germany

Asklepios Klinik Harburg

🇩🇪

Hamburg, Germany

University of Lubeck

🇩🇪

Lubeck, Germany

Universitäts-HNO-Klinik Mannheim

🇩🇪

Mannheim, Germany

Klinikum rechts der Isar der Technischen Universitat Munchen

🇩🇪

Munich, Germany

Klinikum Stuttgart-Katharinenhospital

🇩🇪

Stuttgart, Germany

OLVG

🇳🇱

Amsterdam, Netherlands

St. Antonius Ziekenhuis Nieuwegein

🇳🇱

Nieuwegein, Netherlands

Kantonnspital Baselland-Liestal

🇨🇭

Liestal, Switzerland

© Copyright 2025. All Rights Reserved by MedPath